Home/Filings/4/0001104659-21-129023
4//SEC Filing

HANCOCK DANIEL M 4

Accession 0001104659-21-129023

CIK 0001124524other

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 4:48 PM ET

Size

17.0 KB

Accession

0001104659-21-129023

Insider Transaction Report

Form 4
Period: 2021-10-20
Transactions
  • Exercise/Conversion

    Common Stock

    2021-10-20$14.35/sh+3,783$54,2868,410 total
  • Sale

    Common Stock

    2021-10-20$75.17/sh3,783$284,3854,627 total
  • Sale

    Common Stock

    2021-10-21$76.24/sh5,317$405,3914,627 total
  • Exercise/Conversion

    Option to purchase common stock

    2021-10-203,78311,217 total
    Exercise: $14.35Exp: 2029-05-02Common Stock (3,783 underlying)
  • Exercise/Conversion

    Common Stock

    2021-10-21$14.35/sh+11,217$160,96415,844 total
  • Sale

    Common Stock

    2021-10-21$75.29/sh5,900$444,2059,944 total
  • Exercise/Conversion

    Option to purchase common stock

    2021-10-2111,2170 total
    Exercise: $14.35Exp: 2029-05-02Common Stock (11,217 underlying)
Footnotes (5)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.90 to $75.40, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.90 to $75.89, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.91 to $76.63, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]1/12 of these options vested and became exercisable in equal monthly installments on the 2nd of each month for the twelve (12) months beginning on 05/02/2019.

Issuer

Cryoport, Inc.

CIK 0001124524

Entity typeother

Related Parties

1
  • filerCIK 0001764017

Filing Metadata

Form type
4
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 4:48 PM ET
Size
17.0 KB